FDA draft guidance on generic eye drug push Allergen shares lower
FDA draft guidance on generic eye drug push Allergen shares lower Reuters
View ArticleFor Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy?
For Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy? Motley Fool
View ArticleAllergan climbs after countering FDA draft on generic drug testing
Allergan climbs after countering FDA draft on generic drug testing The Fly on the Wall
View ArticleAllergan pushes FDA to defend Restasis from early generics
Allergan pushes FDA to defend Restasis from early generics Fierce Pharma
View ArticleNew FDA Guidelines Hit This Company Hard
New FDA Guidelines Hit This Company Hard Motley Fool
View ArticleAllergan rides high on patent backing for key drugs Lumigan and Restasis
Allergan rides high on patent backing for key drugs Lumigan and Restasis Fierce Pharma
View ArticleAllergan Slips on Restasis Challenge
Allergan Slips on Restasis Challenge Yahoo/Zacks.com
View Article
More Pages to Explore .....
